Pfizer

PANZYGA

Manufacturer:

Pfizer

Panzyga HCPCS:

J1599

HCPCS Code Descriptor:

Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg

Category:

J Code

Panzyga NDCs:

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Panzyga:

PANZYGA is an Immunoglobulin drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J1599 is aligned to the drug PANZYGA.

Panzyga is a medication that boosts the patient's natural immune system. Panzyga is made with healthy human blood that contains a high level of antibodies, these antibodies act to boost the patient’s immune system. Panzyga can be used to treat a variety of disorders including certain muscle weakness disorders, nerve disorders, and blood vessel disorders. Panzyga is dual manufactured by Pfizer and Octapharma USA.

ACCESS PRICING AND MORE BY REGISTERING

J1599 Added Date:

January 1, 2011

J1599 Effective Date:

January 1, 2011

J1599 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Panzyga billing and coding information.
Our team did not identify a source for Panzyga patient assistance information. Please reach out to our team if you feel that this is a mistake.
PANZYGA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PANZYGA. Please check back in a few weeks.